Search Results

Intestinal Bacteria and Inflammatory Bowel Disease

Authors: Macfarlane, Sandra; Steed, Helen; Macfarlane, George

Source: Critical Reviews in Clinical Laboratory Sciences, Volume 46, Number 1, January 2009 , pp. 25-54(30)

Publisher: Informa Healthcare

Identification and characterization of bacteriophages specific to the catfish pathogen, Edwardsiella ictaluri

Authors: Walakira, J.K.; Carrias, A.A.; Hossain, M.J.; Jones, E.; Terhune, J.S.; Liles, M.R.

Source: Journal of Applied Microbiology, Volume 105, Number 6, December 2008 , pp. 2133-2142(10)

Publisher: Blackwell Publishing

Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics

Authors: Jazayeri, Jalal A.; Carroll, Graeme J.

Source: BioDrugs, Volume 22, Number 1, 2008 , pp. 11-26(16)

Publisher: Adis International

Probiotics: their role in the treatment and prevention of disease

Authors: Doron, Shira; Gorbach, Sherwood L

Source: Expert Review of Anti-Infective Therapy, Volume 4, Number 2, April 2006 , pp. 261-275(15)

Publisher: Expert Reviews

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Authors: Steve H Thorne; David H Kirn

Source: Expert Opinion on Biological Therapy, Volume 4, Number 8, 1 August 2004 , pp. 1307-1321(15)

Publisher: Informa Healthcare

Development of secreted proteins as biotherapeutic agents

Authors: Bonin-Debs A.L.; Boche I.; Gille H.; Brinkmann U.

Source: Expert Opinion on Biological Therapy, Volume 4, Number 4, 1 April 2004 , pp. 551-558(8)

Publisher: Informa Healthcare

Dose–Response Relationship and Mechanism of Action of Saccharomyces boulardii in Castor Oil-Induced Diarrhea in Rats

Authors: Girard P.; Pansart Y.; Lorette I.; Gillardin J-M.

Source: Digestive Diseases and Sciences, Volume 48, Number 4, April 2003 , pp. 770-774(5)

Publisher: Springer

Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects

Authors: Mercenier, A.; Pavan, S.; Pot, B.

Source: Current Pharmaceutical Design, Volume 9, Number 2, January 2003 , pp. 175-191(17)

Publisher: Bentham Science Publishers

Soluble cytokine receptors in biological therapy

Authors: Fernandez-Botran R.; Sun X.; Crespo F.A.

Source: Expert Opinion on Biological Therapy, Volume 2, Number 6, 1 August 2002 , pp. 585-605(21)

Publisher: Informa Healthcare

Pore-Forming Proteins and their Application in Biotechnology

Authors: Panchal R.G.; Smart M.L.; Bowser D.N.; Williams D.A.; Petrou S.

Source: Current Pharmaceutical Biotechnology, Volume 3, Number 2, June 2002 , pp. 99-115(17)

Publisher: Bentham Science Publishers

The biological treatment of renal-cell carcinoma and melanoma

Authors: Nathan P.D.; Eisen T.G.

Source: Lancet Oncology, Volume 3, Number 2, 1 February 2002 , pp. 89-96(8)

Publisher: Elsevier

Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice

Authors: Donskey, C.J.; Hoyen, C.K.; Das, S.M.; Farmer, S.; Dery, M.; Bonomo, R.A.

Source: Letters in Applied Microbiology, Volume 33, Number 1, July 2001 , pp. 84-88(5)

Publisher: Blackwell Publishing

Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice

Authors: Filho-Lima, J. V. M.; Vieira, E. C.; Nicoli, J. R.

Source: Journal of Applied Microbiology, Volume 88, Number 3, March 2000 , pp. 365-370(6)

Publisher: Blackwell Publishing

A Review of the Evidence of Health Claims for Biotherapeutic Agents

Author: Mcfarland L. V.

Source: Microbial Ecology in Health and Disease, Volume 12, Number 2, 29 September 2000 , pp. 65-76(12)

Publisher: Informa Healthcare

Validation of the Probiotic Concept: Lactobacillus reuteri Confers Broad-spectrum Protection against Disease in Humans and Animals

Authors: Casas I.A.; Dobrogosz W.J.

Source: Microbial Ecology in Health and Disease, Volume 12, Number 4, 1 December 2000 , pp. 247-285(39)

Publisher: Informa Healthcare

Biotherapeutic Agents and Infectious Diseases - G. W. Elmer, L. V. McFarland, and C. M. Surawicz; Totowa, NJ, Humana Press, 1999, 304 pages including index.

Author: Balows A.

Source: Diagnostic Microbiology and Infectious Disease, Volume 37, Number 2, June 2000 , pp. 147-147(1)

Publisher: Elsevier

Perspectives on Bifidobacteria as Biotherapeutic Agents in Gastrointestinal Health

Authors: Duffy L.C.; Leavens A.; Griffiths E.; Dryja D.

Source: Digestive Diseases and Sciences, Volume 44, Number 8, 1 August 1999 , pp. 1499-1505(7)

Publisher: Springer

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease

Authors: Lewis, S. J.; Freedman, A. R.

Source: Alimentary Pharmacology & Therapeutics, Volume 12, Number 9, September 1998 , pp. 807-822(16)

Publisher: Blackwell Publishing

Treatment of Clostridium difficile infection

Source: Journal of Antimicrobial Chemotherapy, Volume 41, Supplement 3, 1 May 1998 , pp. 41-46(6)

Publisher: Oxford University Press

Investigation of a pMDI system containing chitosan microspheres and P134a

Authors: Williams III R.O.; Barron M.K.; Jose Alonso M.; Remunan-Lopez C.

Source: International Journal of Pharmaceutics, Volume 174, Number 1, 15 November 1998 , pp. 209-222(14)

Publisher: Elsevier